Department of Pediatrics, Alberta Children's Hospital, University of Calgary, 28 Oki Dr NW, Calgary, Alberta, T3B 6A8, Canada.
Infection Prevention and Control, Alberta Health Services, Calgary, Canada.
J Clin Immunol. 2019 Nov;39(8):753-761. doi: 10.1007/s10875-019-00671-y. Epub 2019 Aug 20.
Severe combined immune deficiency (SCID) is caused by an array of genetic disorders resulting in a diminished adaptive immune system due to impaired T lymphocytes. In these patients, active infection at the time of hematopoietic transplantation has been shown to increase morbidity and mortality. To prevent transmission of infections in SCID patients, standardized infection control precautions should be implemented. An online survey regarding SCID-specific protocols was distributed through several immunodeficiency organizations. Seventy-three responses were obtained, with the majority (55%) of responses from the USA, 15% from Canada, and the remainder from 12 other countries. Only 50% of respondents had a SCID-specific infection control protocol at their center, and while a majority of these centers had training for physicians, a small minority had training for other healthcare workers such as nursing and housekeeping staff. Significant variability of infection control practices, such as in-patient precautions, required personal protective equipment (PPE), diet restrictions, visitor precautions and discharge criteria, was found between different treatment centers. There is a paucity of evidence-based data regarding the safest environment to prevent infection in SCID patients. Institutional protocols may have significant impact on infection risk, survival, family well-being, child development and cost of care. From these results, it is evident that further multi-center research is required to determine the safest and healthiest environment for these children, so that evidence-based infection control protocols for patients with SCID can be developed.
严重联合免疫缺陷症(SCID)是由一系列遗传疾病引起的,由于 T 淋巴细胞受损,导致适应性免疫系统减弱。在这些患者中,造血移植时发生的活动性感染已被证明会增加发病率和死亡率。为了防止 SCID 患者传播感染,应实施标准化的感染控制预防措施。通过多个免疫缺陷组织分发了一份关于 SCID 特异性方案的在线调查。共收到 73 份回复,其中 55%来自美国,15%来自加拿大,其余来自其他 12 个国家。只有 50%的受访者所在中心有 SCID 特异性感染控制方案,而在这些中心中,大多数都为医生提供了培训,但只有少数为其他医护人员(如护理和家政人员)提供了培训。不同治疗中心之间的感染控制实践存在很大差异,例如住院预防措施、所需个人防护设备(PPE)、饮食限制、访客预防措施和出院标准。关于为预防 SCID 患者感染而提供的最安全环境,目前缺乏基于证据的相关数据。机构方案可能会对感染风险、生存、家庭福祉、儿童发育和护理成本产生重大影响。根据这些结果,显然需要进一步进行多中心研究,以确定这些儿童最安全和最健康的环境,从而为 SCID 患者制定基于证据的感染控制方案。